Amazon cover image
Image from Amazon.com

Monoclonal antibody therapy of hematologic malignancies / edited by Bruce D. Cheson

Contributor(s): Series: New frontiers in cancer therapyPublication details: Abingdon, Oxfordshire, U.K. : Darwin Scientific Pub., c2001Edition: 1st editionDescription: x, 287 p. : ill. ; 26 cmISBN:
  • 1903557011
Subject(s): DDC classification:
  • QW 575.5.A6 M751 2001 M751 2001
Contents:
Contents Historical aspects of the development of antibody therapy of B-cell malignancies Monoclonal antibodies-mechanisms of action and resistance Rituximab in the treatment of indolent lymphoma Rituximab in diffuse large B-cell and mantle cell lymphomas Monoclonal antibody therapies for patients with chronic lymphocytic leukamia Rituximab in the less-common CD-20 poitive hematologic magnancies CAMPATH-1H in the treatment of lymphoid malignancies Immunoconjugate therap Radioimmunoconjugates-dosimetric considerations Iodine I 131 tositumomab development and clinical results Clinical development of yttrium-conjugated murine anti-CD20 radioimmunoconjugate for B-cell non-Hodgkin's lymphomas Monoclonal antibodies in acute leukemia Strategies for antibody-chemotherapy combinations in non-Hodgkin's Lymphomas New antibodies and strategies for development Monoclonal antibodies in the treatment of hematologic malignancies-future directions
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Book Open Access Book Open Access Health Sciences Library QW 575.5.A6 M751 2001 (Browse shelf(Opens below)) 1 Available MBAL22010568

Includes references and index

Contents

Historical aspects of the development of antibody therapy of B-cell malignancies

Monoclonal antibodies-mechanisms of action and resistance

Rituximab in the treatment of indolent lymphoma

Rituximab in diffuse large B-cell and mantle cell lymphomas

Monoclonal antibody therapies for patients with chronic lymphocytic leukamia

Rituximab in the less-common CD-20 poitive hematologic magnancies

CAMPATH-1H in the treatment of lymphoid malignancies

Immunoconjugate therap

Radioimmunoconjugates-dosimetric considerations

Iodine I 131 tositumomab development and clinical results

Clinical development of yttrium-conjugated murine anti-CD20 radioimmunoconjugate for B-cell non-Hodgkin's lymphomas

Monoclonal antibodies in acute leukemia

Strategies for antibody-chemotherapy combinations in non-Hodgkin's Lymphomas

New antibodies and strategies for development

Monoclonal antibodies in the treatment of hematologic malignancies-future directions

There are no comments on this title.

to post a comment.